Last updated: February 19, 2026
Doxycycline is a broad-spectrum tetracycline antibiotic used in the treatment of bacterial infections, including respiratory tract infections, urinary tract infections, and certain sexually transmitted diseases. The supply chain for doxycycline involves multiple manufacturers, both branded and generic, with global distribution channels.
Major Manufacturers and Suppliers
| Company |
Country |
Production Capacity |
Notable Brands |
Manufacturing Status |
| Pfizer |
United States |
High |
Vibramycin |
Active |
| Teva Pharmaceutical Industries |
Israel |
Moderate |
Doxycycline Hyclate |
Active |
| Sun Pharmaceutical |
India |
High |
Doxycycline Capsules |
Active |
| Mylan (part of Viatris) |
United States |
Moderate |
Doxycycline Monohydrate |
Active |
| Sandoz (Novartis) |
Switzerland |
Moderate |
Doxycycline Hyclate |
Active |
| Lupin Limited |
India |
Moderate |
Doxycycline Capsules |
Active |
| Apotex |
Canada |
Lower |
Doxycycline Hyclate |
Active |
| Aurobindo Pharma |
India |
Moderate |
Doxycycline Hyclate |
Active |
Generic Doxycycline Sources
The majority of doxycycline supply consists of generic formulations produced by manufacturers in India, China, and other emerging markets. These producers supply both active pharmaceutical ingredients (API) and finished dose forms, including capsules and tablets.
API Suppliers
| Producer |
Country |
API Production Capacity |
Certification |
Notes |
| Zhejiang Hisoar Pharmaceutical |
China |
Large |
GMP |
Active API supplier |
| North China Pharmaceutical Group |
China |
Large |
GMP |
Part of Chinese API export market |
| Shanxi Zhendong Pharmaceutical |
China |
Moderate |
GMP |
Supplies to global markets |
| Xiamen Hisun Pharmaceuticals |
China |
Large |
GMP |
Major API provider |
Finished Dosage Form Suppliers
| Company |
Country |
Product Range |
Manufacturing Capacity |
Distribution Focus |
| Sun Pharmaceutical |
India |
Capsules, tablets |
High |
Global |
| Lupin Limited |
India |
Capsules, tablets, suspensions |
High |
Global |
| Aurobindo Pharma |
India |
Capsules, tablets |
Moderate |
Global |
| Zydus Cadila |
India |
Capsules, tablets |
Moderate |
Global |
Regulatory and Certification Status
Most suppliers hold WHO-GMP (Good Manufacturing Practice), US FDA, or European EMA approval for manufacturing doxycycline APIs and finished products.
- India: Major exporter, with certifications from EC and US FDA.
- China: Large API producer, with GMP certification, exporting worldwide.
- Europe and North America: Suppliers mainly distribute finished products from Indian manufacturers or their own facilities.
Market Dynamics and Supply Risks
- Global demand for doxycycline remains stable but can spike during infectious disease outbreaks.
- Supply chain disruptions in India or China can impact production, given the reliance on raw materials and active ingredients from these regions.
- Regulatory changes, such as increased inspections or export restrictions, may constrict supply flows.
Key Takeaways
- Doxycycline is manufactured by diverse global suppliers, with prominent production in India, China, and North America.
- Indian manufacturers dominate the generic market, primarily producing finished dosage forms.
- API supply is concentrated in Chinese companies with significant export capacity.
- Supply risks include geopolitical tensions, manufacturing disruptions, and regulatory changes.
- Ensuring certification (WHO-GMP, US FDA) maintains quality and supply stability.
FAQs
1. Which companies dominate doxycycline production globally?
Pfizer, Teva, Sun Pharmaceutical, and Lupin are among the largest suppliers for doxycycline APIs and finished products.
2. Are there specific geographic risks for doxycycline supply?
Yes. Heavy reliance on Chinese and Indian manufacturers exposes supply chains to regional disruptions and regulatory changes.
3. What certifications do most suppliers hold?
Most manufacturers possess WHO-GMP, US FDA, and European EMA certifications, ensuring quality standards.
4. Is doxycycline supply influenced by global health emergencies?
Yes. Demand surges during infectious disease outbreaks can strain existing inventories and manufacturing capacities.
5. Who are the main API suppliers for doxycycline?
Chinese companies like Zhejiang Hisoar Pharmaceutical and North China Pharmaceutical Group serve as primary API producers.
References
- U.S. Food and Drug Administration. (2022). Drug Establishments Current Registration Site. Retrieved from https://www.fda.gov
- World Health Organization. (2021). Global Surveillance and Monitoring of Doxycycline Markets. WHO Publications.
- Pharma Intelligence. (2022). Global API Market Report.
- Indian Pharmaceutical Alliance. (2021). Indian Generics Industry Profile.
- European Medicines Agency. (2022). List of Certified API Manufacturers.
